| Name | Title | Contact Details |
|---|---|---|
Michael Seidelman |
Chief Information Security Officer | Profile |
Prentis Brooks |
Head Of Information Security | Profile |
IDEX Health & Science is the global authority in fluidics and optics` bringing life to advanced optofluidic technologies with our products` people and engineering expertise. We are respected worldwide for solving complex problems and delivering complete path innovation for analytical` diagnostic and biotechnology applications for the life sciences market. As a genuine and trustworthy partner` we solve our customers’ most demanding challenges with the industry`s most extensive portfolio of state-of-the-art components and capabilities that are unrivaled in breadth` quality` performance and design. Our vision of the complete path goes far beyond just meeting our customers’ needs — it anticipates them` with intelligent solutions for life.
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as ringing in the ears.
NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.
ZLB Plasma Services is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Palomar Medical Technologies, Inc. is a Burlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.